tiprankstipranks
Aurinia Pharmaceuticals (AUPH)
NASDAQ:AUPH
AUPH
Aurinia Pharmaceuticals
RESEARCH TOOLSreports
Want to see AUPH full AI Analyst Report?

Aurinia Pharmaceuticals (AUPH) Revenue

2,145 Followers
StatisticsMarket CapRevenue

Aurinia Pharmaceuticals Revenue

Aurinia Pharmaceuticals had a revenue of 77.70M in the quarter ending Mar 31, 2026, with 0.77%. This bring the company's revenue in the last twelve months to 298.30M, Decreased 5.38%. In the fiscal year ending Dec 31, 2025, Aurinia Pharmaceuticals had annual revenue of 283.06M with 20.38% growth.
Revenue (ttm)
298.30M
Revenue Growth
20.62%
P/S Ratio
7.83
Revenue/Employee
$2,177,346
Employees
130
Market Cap
$2.22B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
283.06M47.92M+20.38%
Dec 31, 2024
235.13M59.62M+33.97%
Dec 31, 2023
175.51M41.48M+30.95%
Dec 31, 2022
134.03M88.42M+193.89%
Dec 31, 2021
45.60M-4.51M-9.00%
Dec 31, 2020
50.12M49.80M+15,660.38%
Dec 31, 2019
318.00K-145.00K-31.32%
Dec 31, 2018
463.00K43.00K+10.24%
Dec 31, 2017
420.00K――